Cas:220497-61-0 Fmoc-Gly(cyclopentyl)-OH manufacturer & supplier

Chemical Name:Fmoc-Gly(cyclopentyl)-OH

CAS.NO:220497-61-0

Synonyms:(S)-cyclopentyl({[(9H-fluoren-9-ylmethoxy)carbonyl]amino})acetic acid;(2S)-Cyclopentyl{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid;Fmoc-cyclopentyl-Gly-OH;AmbotzFAA1360;FMOC-L-CYCLOPENTYLGLYCINE;Cyclopentaneacetic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αS)-;Fmoc-Gly(cyclopentyl)-OH

Molecular Formula:C₂₂H₂₃NO₄

Molecular Weight:365.422

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:590.5±33.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.612

PSA:75.63000

Exact Mass:365.162720

LogP:5.04

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (S)-cyclopentyl({[(9H-fluoren-9-ylmethoxy)carbonyl]amino})acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-Gly(cyclopentyl)-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fmoc-cyclopentyl-Gly-OH Use and application,FMOC-L-CYCLOPENTYLGLYCINE technical grade,usp/ep/jp grade.

Related News: The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually. 2-acetamido-3,5-dimethoxybenzenesulfonyl chloride manufacturers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. methyl 2-O-acetyl-3-O-(2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl)-α-D-mannopyranoside suppliers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. N-[4-(Diethylamino)phenyl]cyclobutanecarboxamide vendor & factory.